National HealthCare (NYSEAMERICAN:NHC) Reaches New 12-Month High – Here’s What Happened

Posted by George Bondi on Oct 23rd, 2026

National HealthCare Corporation (NYSEAMERICAN:NHC – Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday. The company traded as high as $247.94 and last traded at $247.94, with a volume of 128,475 shares changing hands. The stock had previously closed at $239.24.

National HealthCare Stock Up 3.2%

The company’s 50-day moving average is $227.44 and its 200-day moving average is $207.83. The stock has a market capitalization of $3.81 billion, a price-to-earnings ratio of 33.95 and a beta of 0.60.

National HealthCare (NYSEAMERICAN:NHC – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%. The business had revenue of $408.03 million during the quarter.

National HealthCare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.67 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.68 annualized dividend and a yield of 1.1%. National HealthCare’s dividend payout ratio (DPR) is 61.89%.

Insider Activity at National HealthCare

In other news, CFO Brian F. Kidd sold 6,813 shares of the stock in a transaction on Friday, September 11th. The stock was sold at an average price of $225.70, for a total transaction of $1,537,694.10. Following the completion of the transaction, the chief financial officer directly owned 23,183 shares in the company, valued at approximately $5,232,403.10. This represents a 22.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Josh A. Mccreary sold 2,719 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $224.23, for a total value of $609,681.37. Following the transaction, the vice president owned 9,979 shares of the company’s stock, valued at approximately $2,237,591.17. This represents a 21.41% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 17,645 shares of company stock valued at $3,991,668 over the last 90 days. Corporate insiders own 13.92% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of NHC. BlackRock Inc. acquired a new stake in shares of National HealthCare during the second quarter valued at about $417,602,000. Morgan Stanley Institutional Investment Advisors LLC purchased a new stake in shares of National HealthCare in the 2nd quarter valued at approximately $217,391,000. First Trust Advisors LP raised its stake in shares of National HealthCare by 45.4% in the 1st quarter. First Trust Advisors LP now owns 530,302 shares of the company’s stock valued at $84,689,000 after acquiring an additional 165,615 shares during the period. Bank of New York Mellon Corp acquired a new position in shares of National HealthCare in the 2nd quarter worth approximately $25,854,000. Finally, Manatuck Hill Partners LLC acquired a new position in shares of National HealthCare in the 2nd quarter worth approximately $12,561,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

National HealthCare Company Profile

(Get Free Report)

National HealthCare Corporation (NHC) is a provider of post-acute and senior healthcare services. The company operates skilled nursing centers, assisted living and memory care communities, and rehabilitation facilities. Its services are designed to support patients recovering from illness or injury, as well as older adults requiring long-term residential care.

NHC also provides home healthcare, hospice, and private-duty nursing services, allowing patients to receive medical and supportive care in their homes or in hospice settings.